Compare Crescentis Capit with Similar Stocks
Stock DNA
Non Banking Financial Company (NBFC)
INR 180 Cr (Micro Cap)
NA (Loss Making)
21
0.00%
0.00
-4.04%
2.19
Total Returns (Price + Dividend) 
Latest dividend: 1.0000 per share ex-dividend date: Sep-07-2011
Risk Adjusted Returns v/s 
Returns Beta
News

Crescentis Capital Ltd is Rated Strong Sell
Crescentis Capital Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 29 June 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 12 July 2026, providing investors with the most up-to-date view of the company’s fundamentals, returns, and market performance.
Read full news article
Crescentis Capital Ltd Downgraded to Strong Sell Amid Weak Financials and Mixed Technicals
Crescentis Capital Ltd, a micro-cap player in the Non Banking Financial Company (NBFC) sector, has seen its investment rating downgraded from Sell to Strong Sell as of 29 June 2026. This shift reflects deteriorating financial fundamentals, mixed technical indicators, and valuation concerns, despite the stock’s recent market-beating returns over the past year.
Read full news article
Crescentis Capital Ltd Upgraded to Sell on Improved Technicals Despite Weak Financials
Crescentis Capital Ltd, a micro-cap player in the Non Banking Financial Company (NBFC) sector, has seen its investment rating upgraded from Strong Sell to Sell as of 22 June 2026. This change reflects a nuanced assessment across four key parameters: quality, valuation, financial trend, and technicals. While the company continues to grapple with weak fundamentals and negative earnings, improved technical indicators have prompted a more favourable outlook from analysts.
Read full news article Announcements 
Resignation Of Senior Management Personnel Of The Company.
16-Jul-2026 | Source : BSEDisclosure u/r 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 - Resignation of Mr. Sai Kumar Subramanya - Senior Management Personnel of the Company. Brief details are attached in the Annexure.
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018
09-Jul-2026 | Source : BSECertificate Under Regulation 74(5) of SEBI(Depositiories and Participants) Regulations 2018 for the Quarter ended 30th June 2026
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011
29-Jun-2026 | Source : BSEThe Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Bhavanam Ruthvik Reddy & Dr. Bhaskar Rao Bollineni
Corporate Actions 
No Upcoming Board Meetings
Crescentis Capital Ltd has declared 10% dividend, ex-date: 07 Sep 11
No Splits history available
No Bonus history available
Crescentis Capital Ltd has announced 7:10 rights issue, ex-date: 06 Jun 25
Quality key factors 
Valuation key factors
Technicals key factors
Shareholding Snapshot : Jun 2026
Shareholding Compare (%holding) 
Promoters
None
Held by 0 Schemes
Held by 0 FIIs
Bhaskara Rao Bollineni (67.04%)
Soptex Developements Limited (1.45%)
19.87%
Quarterly Results Snapshot (Standalone) - Mar'26 - QoQ
QoQ Growth in quarter ended Mar 2026 is -300.00% vs 1,330.77% in Dec 2025
QoQ Growth in quarter ended Mar 2026 is -717.65% vs 347.92% in Dec 2025
Half Yearly Results Snapshot (Standalone) - Sep'25
Growth in half year ended Sep 2025 is 4.83% vs -28.08% in Sep 2024
Growth in half year ended Sep 2025 is 8.71% vs -54.56% in Sep 2024
Nine Monthly Results Snapshot (Standalone) - Dec'25
YoY Growth in nine months ended Dec 2025 is 1,175.71% vs -93.86% in Dec 2024
YoY Growth in nine months ended Dec 2025 is 346.06% vs -117.61% in Dec 2024
Annual Results Snapshot (Standalone) - Mar'26
YoY Growth in year ended Mar 2026 is 149.01% vs -120.09% in Mar 2025
YoY Growth in year ended Mar 2026 is 53.32% vs -144.79% in Mar 2025






